Vol 8, Supplement 2 (September 2019): Translational Lung Cancer Research (Recent Developments in Radiotherapy for Lung Cancer)

Review Article

Pathologic response after modern radiotherapy for non-small cell lung cancer
Simon F. Roy, Alexander V. Louie, Moishe Liberman, Philip Wong, Houda Bahig
Safety of stereotactic ablative body radiation for ultracentral stage I non-small cell lung cancer
Abraham Jing-Ching Wu
PACIFIC: shifting tides in the treatment of locally advanced non-small cell lung cancer
Andrew Bang, Jonathan D. Schoenfeld, Alexander Y. Sun
Recent developments in limited stage small cell lung cancer
Kristin A. Higgins, Sophia Gorgens, Lisa J. Sudmeier, Corinne Faivre-Finn
What is the role of radiotherapy for extensive-stage small cell lung cancer in the immunotherapy era?
Eric G. Nesbit, Ticiana A. Leal, Tim J. Kruser
What is the optimal radiotherapy utilization rate for lung cancer?—a systematic review
Wei Liu, Alissa Liu, Jessica Chan, R. Gabriel Boldt, Pablo Munoz-Schuffenegger, Alexander V. Louie
Strengths and limitations of large databases in lung cancer radiation oncology research
Vikram Jairam, Henry S. Park
Changing equipoise in the landscape of radiation for oligometastatic lung cancer
Samuel R. Schroeder, Michael Leenders, Puneeth Iyengar, Dirk de Ruysscher
Current landscape of palliative radiotherapy for non-small-cell lung cancer
Raphael Jumeau, Florent Vilotte, André-Dante Durham, Esat-Mahmut Ozsahin
Proton therapy for non-small cell lung cancer: the road ahead
Eric D. Brooks, Matthew S. Ning, Vivek Verma, X. Ronald Zhu, Joe Y. Chang
Management of local recurrences and regional failure in early stage non-small cell lung cancer after stereotactic body radiation therapy
Sameera S. Kumar, Ronald C. McGarry


The supplement “Recent Developments in Radiotherapy for Lung Cancer” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Alexander V. Louie, Houda Bahig and Drew Moghanaki served as the unpaid Guest Editors for the supplement.